Format

Send to

Choose Destination
Int J Tuberc Lung Dis. 2016 Jul;20(7):991-2. doi: 10.5588/ijtld.16.0201.

A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugs.

Author information

1
Maternal-Fetal Medicine Division, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco (UCSF), USA.
2
Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, UCSF, USA.
3
Department of Epidemiology and Biostatistics, UCSF, USA.
4
Curry International Tuberculosis Center, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, UCSF, California, USA. john.metcalfe@ucsf.edu.
PMID:
27287660
PMCID:
PMC5119745
DOI:
10.5588/ijtld.16.0201
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Ingenta plc Icon for PubMed Central
Loading ...
Support Center